Signant’s comprehensive clinical research solutions help glioblastoma multiforme (GBM) studies succeed by improving data quality, reducing patient burdens, and enabling efficient operations.

With our full range of technology solutions, as well as in-house scientific and trial operations expertise, study teams will:

• Capture better-quality, more comprehensive assessment and patient function data
• Streamline and control consent, reconsent, and ICF version management
• Minimize patient burdens
• Manage study randomization complexities and investigational products more efficiently

Learn how by downloading the brochure.